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Abstract
Background: Gold nanoparticles (AuNPs) are finding increased use in therapeutics and imaging. However, their
toxic effects still remain to be elucidated. Therefore this study was undertaken to study the biochemical effects of
AuNPs on rat brain and identify potential biomarkers of AuNP toxicity.
Methods: Male Wister rats weighing 150–200 g were injected with 20 μg/kg body weight of 20-nm gold
nanoparticles for 3 days through the intraperitoneal route. The rats were killed by carbon dioxide asphyxiation 24 h
after the last dose of gold nanoparticle injection. The parameters studied included lipid peroxidation, glutathione
peroxidase, 8- hydroxydeoxyguanosine, caspase-3, heat shock protein70, serotonin, dopamine, gamma amino-
butyric acid and interferon-γ.
Results: In this study AuNPs caused generation of oxidative stress and a decrease of antioxidant enzyme, viz.,
glutathione peroxidase activity in rat brain. This was accompanied by an increase in 8-hydroxydeoxyguanosine,
caspase-3 and heat shock protein70, which might lead to DNA damage and cell death. Gold nanoparticles also
caused a significant decrease in the levels of neurotransmitters like dopamine and serotonin, indicating a possible
change in the behavior of the treated animals. There was a significant increase in the cerebral levels of IFN-γ in
treated animals.
Conclusion: This study concludes that AuNPs cause generation of oxidative stress and an impairment of the
antioxidant enzyme glutathione peroxidase in rat brain. AuNPs also cause generation of 8-hydroxydeoxyguanosine
(8OHdG), caspase-3 and heat shock protein70 (Hsp70), and IFN-γ, which may lead to inflammation and DNA
damage/cell death.
Keywords: Gold nanoparticles, Oxidative stress, Antioxidant enzyme, DNA damage, Cell death, Interferon-γ,
Neurotransmitters
Background
The emerging field of nanobiotechnology offers the po-
tential for the development of exquisitely sensitive diag-
nostics and organ/tumor-targeted therapies [1]. Over the
past few decades, there has been considerable interest in
developing nanoparticles as effective drug delivery
devices [1]. Gold nanoparticles (AuNPs) are expected to
have a wide range of applications in the future because
they are easy to synthesize and have good biocompatibi-
lity. Studies of Sonavan et al. 2008 [1] have demon-
strated a wide distribution of gold particles inside the
living system. Their studies have shown that 15–50-nm
AuNPs can cross the blood–brain barrier, resulting in
their accumulation in the brain [1]. The biosafety of me-
tallic gold in well known, and it has been in in vivo use
since the 1950s [2]. However, it is essential to under-
stand the interaction of gold nanoparticles with vital
organs such as the brain, liver, kidneys, heart, etc. The
toxicity of nanoparticles in vivo is determined by many
parameters, such as dose, routes of exposure, metabol-
ism, excretion, and immune response. The toxicological
profiles of nanomaterials are determined by their chem-
ical composition, size, shape, aggregation and surface
coating [2]. Nanoparticle technology also holds promises
to treat diseases like Alzheimer’s and Parkinson’s dis-
eases. Nevertheless, effective targeting of drugs to the
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brain remains a challenge because of the restrictive
properties of the blood–brain barrier (BBB). This barrier,
predominantly formed by endothelial cells that are phys-
ically joined by tight junctions in their external mem-
branes, limits the molecular exchange to transcellular
transport, thus restricting the passage of molecules
across the barrier. The healthy BBB also largely protects
the brain from blood-borne nanoparticle exposure; how-
ever, a number of pathologies, including hypertension
and allergic encephalomyelitis, have been shown to in-
crease BBB permeability to nanoparticles [3]. The wide-
spread use of nanoparticles in the future is likely to have
an enormous impact on human health. Therefore, it is
essential to understand the effects of nanoparticles on
the brain, which is one of the vital organs of the body.
This study was undertaken to investigate the effect of




Male Wister rats weighing 150–200 g were obtained
from the animal house of the Pharmacy College of King
Saud University, Riyadh. After 1 week of acclimatization,
the rats were injected with 20 μg/kg body weight of
20-nm gold nanoparticles for 3 days through the intra-
peritoneal route. The rats were killed by carbon dioxide
asphyxiation 24 h after the last dose of gold nanoparticle
injection. Ethical animal care guidelines were followed.
Chemicals
All the chemicals used were purchased from Sigma
Chemical C., St Louis, MO, USA. Double-distilled water
was used throughout the study.
Gold nanoparticles (AuNPs)
Gold nanoparticles of 20 nm (Product MKN-Au-020,
Canada) in aqueous solution of 0.01% gold concentra-
tion were used in this study.
Preparation of sample
The rats were killed by carbon dioxide asphyxiation 24 h
after the last dose of gold nanoparticle injection. The
brains were dissected out, washed in ice-cold saline and
homogenized in saline (10% weight/volume) at 40 C.
The homogenates were centrifuged at 3,000 rpm for 10
min in a cooling centrifuge. The supernatant was used
in the study.
Parameters related to oxidative stress
Lipid peroxidation
Lipid peroxidation was measured by measuring the level
of malondialdehyde (MDA) by the method of Buege and
Aust, 1978 [4]. 0.25 ml of homogenate was mixed with
0.75 ml of double-distilled water and incubated in a
shaking water bath at 370 C for 1 h. The reaction was
stopped by adding 1.5 ml of 20% trichloroacetic acid.
The reaction mixture was centrifuged at 3,000 rpm for
10 minutes. Then 1 ml of 0.67% thiobarbituric acid was
added to 1 ml of the supernatant, and the reaction mix-
ture was incubated at 100°C for 10 min. On cooling ab-
sorbance was read at 535 using a reagent blank.
Values were expressed as moles of thiobarbituric-acid
reactive substances formed/h/mg protein.
Glutathione peroxidase (GPx)
GPx activity was determined by the method of Wendel
A, 1981 [5], with modifications. The mixture contained
0.6 ml of 0.25 M phosphate buffer (pH 7.0), 0.3 ml of 10
mM GSH, 0.3 ml of 10 mM EDTA, 0.3 ml of 10 mM so-
dium azide, 0.3 ml of 2 mM NADPH and 20 μl glutathi-
one reductase. The mixture was added to 0.9 ml of the
sample and incubated at 30 °C for 5 min. The reaction
was initiated by the addition of 0.3 ml of 2.5 mM hydro-
gen peroxide. The absorbance was immediately read at
340 nm.
Parameters related to DNA damage and apoptosis
8- hydroxydeoxyguanosine (8OHdG)
8-Hydroxydesoxyguanosine was determined using the
Bluegene Elisa kit from Life Sciences Advanced Tech-
nologies, Inc., Saint Petersburg, FL, USA, using the man-
ufacturer’s instructions.
Caspase-3
Caspase-3 was measured using an ELISA kit from Cusa-
bio. The concentration of caspase-3 was determined
according to the manufacturer’s instructions.
Heat shock protein70 (Hsp70)
Hsp70 was measured in homogenates of brain using an
ELISA kit (Uscn Life Science Inc., Wuhan, China)
according to the manufacturer’s instructions.
Neurotransmitters
Assay of serotonin
Serotonin was measured using an ELISA kit, a product
of Immuno-Biological Laboratories, Inc. (IBL-America),
Minneapolis, MN, USA.
Dopamine
Dopamine was extracted by using a cis-diol-specific af-
finity gel, acylated and then derivatized enzymatically.
Quantitative assay was performed using an ELISA kit, a
product of Immuno-Biological Laboratories, Inc. (IBL-
America).
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Assay of gamma amino-butyric acid (GABA)
Quantitative determination of GABA was done using an
ELISA immunoassay kit, a product of ALPCO, UK.
Parameter related to inflammation
Interferon-γ (IFN-γ)
IFN-γ was measured using an ELISA kit, a product of
Thermo Scientific, Waltham, MA, USA, according to
the manufacturer’s instructions.
Statistical analysis
A computer SPSS program was used, and the results
were expressed as mean ± SD (n= 6). Comparisons were
made by the one-way ANOVA between the control and
treated groups. Dunnett’s test was used to compare be-
tween the groups. Receiver operating characteristic ana-
lysis was done. Area under the curve, specificity and
sensitivity were calculated.
Results and discussion
Neurons are nerve cells that, together with neuroglial
cells, constitute the nervous tissue making up the ner-
vous system. A neuron consists of a nerve cell body (or
soma), axon and dendrites. Neurons receive nerve sig-
nals (action potentials), integrate action potentials and
transmit the signals to other neurons [6]. Although the
human nervous system is much more specialized and
complicated than that of lower animals, the structure
and function of neurons is essentially the same in all ani-
mals [6]. In vitro systems to study the effects of nanopar-
ticles on the nervous system have included neuron and
nanoparticle cultures to determine the effects on neur-
onal functions [7]. Endpoints could include reactive
oxygen species/reactive nitrogen species production,
apoptosis, metabolic status, effects on the action po-
tential and ion regulation in general [7]. Human neural
cells, such as hippocampal cells in the central nervous
system, are the most sensitive and delicate cells in
bioorganisms, and are responsible for brain functions
and emotions. They are vulnerable to ischemia, oxygen
deficiency and external factors. One of the concerns in
science and technological development in the twenty-
first century is that nanoparticles may produce poten-
tial functional and toxic effects on human neural cells
owing to their ability to pass through biological mem-
branes [8].
The high proportion of surface atoms/molecules can
give rise to a greater chemical as well as biological activity,
for example the induction of reactive oxygen species in
cell-free medium as well as in cells [9]. Nanoparticles are
able to translocate across cell barriers from the portal of
entry (e.g., the respiratory tract) to secondary organs, and
to enter cells by various mechanisms and associate with
subcellular structures. This makes nanoparticles uniquely
suitable for therapeutic and diagnostic uses, but it also
leaves target organs such as the central nervous system
vulnerable to potential adverse effects (e.g., oxidative
stress) [9]. In general, translocation rates of NPs from the
portal of entry into the blood compartment or the central
nervous system (CNS) are very low. Important modifiers
of translocation are the physicochemical characteristics of
NPs, most notably their size and surface properties, par-
ticularly surface chemistry [9]. Increased surface reactivity
would imply that the nanoparticles would exhibit
increased biological activity. The increased biological ac-
tivity of nanoparticles could be useful to penetrate cells
for drug delivery. However, undesirable effects of nanopar-
ticles could include generation of oxidative stress and/or
impairment of antioxidant defense responses.
In the present study gold nanoparticles caused signifi-
cant generation of oxidative stress in the brain. This is
evident by an increased lipid peroxidation of 46%
(P< 0.001) in the brains of rats treated with gold nano-
particles when compared to the brains of control rats
(Figure 1). Malondialdehyde (MDA) is the end product
of lipid peroxidation, and an increase in the level of
MDA suggests higher lipid peroxidation. Oxidative stress
has been identified as a likely mechanism of nanoparticle
toxicity [10].
Increased malondialdehyde production was accompan-
ied by a significant decrease (P <0.001) of 21% glutathi-
one peroxidase in the brains of treated rats when
compared to control group of rats (Figure 1). Glutathi-
one peroxidase (GPx) is one of the important antioxi-
dant enzymes involved in protecting the cell against
oxidative stress. The glutathione redox cycle is a major
source of protection against mild oxidative stress [11].
GPx, a selenium-containing antioxidative enzyme scav-



























Figure 1 Effect of gold nanoparticles on lipid peroxidation,
glutathione peroxidase, 8- hydroxydeoxyguanosine, caspase-3
and heat shock protein 70 in rat brain. ***P< 0.001 Dunnett’s
test.
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inhibitor of lipid peroxidation. GPx has been reported to
protect the cell against peroxidative damage [12]. In this
study there was a negative correlation between MDA and
GPx, which might indicate an impairment of antioxidant
defenses in the brain by the free radicals generated by
AuNP (Figure 2a).
Gold nanoparticles also caused a significant increase in 8-
hydroxydeoxyguanosine (8OHdG), caspase-3 and heat
shock protein 70 (Hsp70) by 57%, 38% and 45%, respect-
ively, in the brains of treated rats when compared to the
control group (Figure 1). There was also a positive correl-
ation between MDA and 8-hydroxydeoxyguanosine
(8OHdG), caspase-3 and heat shock protein 70 (Hsp70)
(Figures 2b, c, d). Oxidative stress is considered one of the
foremost reasons for DNA damage. Reactive oxygen species
generated in metabolizing cells could attack DNA base
guanine forming the 8-OHdG lesions, which is known to
have mutagenic potential and hence used routinely as a bio-
marker for carcinogenesis [13]. AuNPs have been reported
Figure 3 Effect of gold nanoparticles on serotonin, dopamine,
gamma aminobutyric acid and interferon-γ in rat brain.
***P< 0.001 Dunnett’s test.
Figure 2 (a) Correlation between MDA (UM/100 mg) and GPx (U/100 mg) with best fit line curve (negative correlation). (b) Correlation
between MDA (UM/100 mg) and 8-OHdG (Pg/100 mg) with best-fit line curve (positive correlation). (c) Correlation between MDA (UM/100 mg)
and caspase-3 (ng/100 mg) with best-fit line curve (positive correlation). (d) Correlation between MDA (UM/100 mg) and Hsp70 (ng/100 mg) with
best-fit line curve (positive correlation). (e) Correlation between MDA (UM/100 mg) and INFγ (ng/100 mg) with best-fit line curve (positive
correlation).
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to induce DNA damage in the form of single-strand lesions
in human lung fibroblasts [14].
The brain is particularly susceptible to oxidative
stress-induced damage because of its (1) high oxygen
consumption to maintain metabolism, (2) high content
of polyunsaturated fatty acids with their oxidatively sus-
ceptible allylic hydrogen atoms, (3) relatively high con-
centration of iron and ascorbate to carry out the radical-
generating Fenton reaction, and (4) relatively low con-
centration of antioxidants and antioxidant enzymes [15].
Caspases are crucial mediators of programmed cell death
(apoptosis) [16]. Among them, caspase-3 is a frequently
activated death protease, catalyzing the specific cleavage of
many key cellular proteins. Pathways to caspase-3 activa-
tion have been identified that are either dependent on or
independent of mitochondrial cytochrome c release and
caspase-9 function. Caspase-3 is essential for normal brain
development, and is important or essential in other apop-
totic scenarios in a remarkable tissue-, cell type- or death
stimulus-specific manner. Caspase-3 is also required for
some typical hallmarks of apoptosis, and is indispensable
for apoptotic chromatin condensation and DNA fragmen-
tation in all cell types examined [16]. In the present study, a
significant increase in caspase-3 along with 8OHdG (Fig-
ure 1) may indicate activation of apoptotic machinery in
the brain after nanoparticle injection. Zehendner et al.
(2011) have also implicated caspase-3 in various neurode-
generative disorders [17].
Heat shock proteins play a role in protecting cells from
damage generated by a variety of stress. Different cytopro-
tective effects attributed to heat shock proteins include
refolded and misfolded proteins, degradation of unstable
proteins, prevention of protein aggregation, etc. [18]. In the
present study AuNPs caused a significant increase in
Hsp70 (Figure 1), which may be due to the generation of
oxidative stress in the brain. There was a positive correl-
ation between the malonaldehyde generated as a result of
lipid peroxidation and Hsp70 (Figure 2d).
Figure 4 (a) ROC curve of INFγ (ng/100 mg), MDA (UM/100 mg), Hsp70 (ng/100 mg), caspase-3 (ng/100 mg) and 8-OHdG (Pg/100 mg)
in gold nanoparticle-treated group. (b) ROC Curve of GPx (U/100 mg), serotonin (ng/10 mg), dopamine (ng/10 mg) and GABA (ng/10 mg) in
gold nanoparticle-treated group.
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Dopamine and serotonin are neurotransmitters, which
are found in neurons of all animals. Alteration in the
normal expression of these transmitters is associated
with human neurological disorders such as Parkinson’s
disease and depression [19,20]. AuNPs also cause a sig-
nificant decrease in serotonin (P< 0.001) and dopamine
(P <0.01), but no significant change in gamma amino
butyric acid (Figure 3) in rat brains. Serotonin has been
reported to have an inhibitory action in brain [21].
Dopamine is a neurotransmitter involved in modulating
aggressive behavior in animals [22]. AuNPs have been
shown to activate neurotransmitter enzymes like 1-
cholineesterase and monoamine oxidase [23].
Gold nanoparticle injection also caused a significant in-
crease (P< 0.001) in the level of interferon γ when com-
pared to the control group of rats (Figure 3). The increase
in the concentration of interferon γ demonstrates the in-
flammatory potential of AuNPs [24]. Palladium nanoparti-
cles have been shown to induce IFN-γ release and increase
the expression of IFN- γ mRNA from peripheral blood
mononuclear cells [25]. Figure 4 shows ROC analysis of the
measured parameters. The results demonstrate that IFN-γ,
MDA, HSP70, caspase-3 and 8-OHdG demonstrated more
than 80% sensitivity and therefore can be used as biomar-
kers of gold nanoparticle toxicity.
Conclusion
This study concludes that AuNPs cause the generation
of oxidative stress and an impairment of the antioxidant
enzyme glutathione peroxidase in rat brain. AuNPs
cause the generation of 8-hydroxydeoxyguanosine
(8OHdG), caspase-3, heat shock protein 70 (Hsp70), and
IFN-γ, which may lead to inflammation and DNA dam-
age/cell death. Gold nanoparticle treatment also caused
a significant decrease in the levels of neurotransmitters
such as dopamine and serotonin, indicating a possible
change in the behavior of the treated animals (Figure 5).
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